Exact Sciences (EXAS) Cost of Revenue (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Cost of Revenue data on file, last reported at $288.5 million in Q4 2025.

• Cost of Revenue for Q4 2025 came in at $288.5 million, up 17.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $992.1 million (up 10.96% YoY), and the FY2025 annual result was $1.1 billion, up 17.45% from the prior year.
• Cost of Revenue rose to $288.5 million in Q4 2025 per EXAS's latest filing, from $250.2 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $288.5 million in Q4 2025 and troughed at $110.0 million in Q1 2021.
• A 5-year average of $192.8 million and a median of $199.6 million in 2023 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2021 and 2022: Cost of Revenue jumped 150.12% in 2021, then slipped 25.78% in 2022.
• A 5-year view of Cost of Revenue shows it stood at $119.1 million in 2021, then surged by 96.64% to $234.1 million in 2022, then decreased by 17.58% to $193.0 million in 2023, then climbed by 26.72% to $244.5 million in 2024, then advanced by 17.99% to $288.5 million in 2025.
• Business Quant data shows EXAS's Cost of Revenue at $288.5 million in Q4 2025, $250.2 million in Q3 2025, and $247.1 million in Q2 2025.